Publication date: Jul 05, 2023
Identifying individuals and factors associated with severe cases of COVID-19 is crucial as the pandemic continues to spread globally. Effective biomarkers for predicting severe cases are essential for optimizing clinical management, therapy, and preventing unfavorable outcomes. This exploratory observational study aimed to investigate the expression of dysregulated immune response genes (ARG1, NOS2, ITGA4, and SELPLG) in total leukocytes, plasmatic levels of P-selectin and PSGL-1, and their clinical associations in patients with mild and severe COVID-19. Data from 117 confirmed COVID-19 patients (severe = 58, mild = 59) were collected upon admission. Gene expression was measured using RT-qPCR, and plasma protein levels assessed with ELISA assay. The severe COVID-19 patient group had a higher median age of 62. 0 (p = 0. 0001), a higher proportion of black individuals (86. 2%, p
| Concepts | Keywords |
|---|---|
| Elisa | COVID-19 |
| Immunopharmacol | Dysregulated leucocyte response |
| Severe | Endothelial activation |
| Therapy | P-selectin |
| PSGL1 |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | immune response |
| disease | MESH | COVID-19 |
| disease | VO | effective |
| disease | IDO | assay |